Christoph Schultheiß

30PUBLICATIONS
159CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunitySolid tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 20, 2026
α2,3-sialylation on human naïve T cells restrains bispecific engager-mediated anti-tumor immunity.

|Aug 12, 2026
FGL-1 plasma levels correlate with markers of inflammation and severe disease during SARS-CoV-2 infection.

|Jul 14, 2026
Toward precision immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: lessons from the FOCUS trial.

|Jul 06, 2026
OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

|Jun 05, 2026
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|Apr 13, 2026
Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia.

Sujal Ghosh, Yuqin Wang, Christoph Schultheiss

Pageof 5

Frequent Collaborators

20 joint publications

Mascha Binder

9 joint publications

Lisa Paschold

6 joint publications

Edith Willscher

3 joint publications

Heinz Läubli